Imspired by a patient.
Godfrey's search for relief pointed her to an unapproved and
costly treatment for depression — ketamine. An animal anesthetic best known as
the addictive party drug "Special K," ketamine was approved for use
as a human anesthetic in 1970 and it's often used in emergency care to sedate
kids and patients with breathing problems.
Low, intravenous doses have been found to boost mood and
curb suicidal thoughts, but the U.S. Food and Drug Administration has not
approved it as a treatment for depression. And the American Psychiatric
Association (APA) warns patients about the potential for abuse and the lack of
large, long-term studies of its effectiveness.
Even so, ketamine clinics like the one now treating Godfrey
are springing up across the United States.
"The lack of information is really quite dramatic when
you look at the proliferation of use in certain communities," said former
APA President Dr. Alan Schatzberg. He helped write an APA statement about
ketamine last year urging caution.
"We just don't know about whether people will develop
tolerance, whether there is a risk for dependence, whether there are
unidentified side effects — there are no data on use of ketamine beyond four
weeks," Schatzberg said.
The drug is not designed for continuing use, Schatzberg
added, and can cause psychotic reactions — including hallucinations and
dissociation, a sense of being disconnected from one's body and the world.
It's not even clear exactly how ketamine works to improve
mood, he said.
A common theory is that it affects the brain's response to
the neurotransmitter glutamate. Neurotransmitters are chemicals that send
signals from one part of the brain to another and from the brain to the body.
Essentially, the thinking goes, ketamine rewires the brain.
But Schatzberg, a professor of psychiatry and behavioral
sciences at Stanford University, was part of a small study published online
recently in The American Journal of Psychiatry. It suggests another explanation
— that ketamine somehow activates opioid receptors in the brain.
"We could be exposing people to untoward consequences
from a drug that works through an opioid mechanism," he said. "We
need to study it more."
Dr. Robert Watson, Godfrey's doctor at Sierra Ketamine
Clinics in Reno, agrees that more study is needed. He thinks researchers could
learn much from clinics like his that offer ketamine as an off-label depression
treatment.
Watson said he's seen the drug help many patients whose
depression hasn't responded to other medications and/or talk therapy.
Since opening late last year, his clinic has treated about
500 patients — roughly 75 percent of them for chronic depression. It also uses
ketamine to treat some other mental health problems, including post-traumatic
stress, as well as chronic pain.
For depression, patients get four to six infusions, twice a
week. Because the treatment is not FDA-approved, insurance rarely covers the
cost, which averages $500 per dose. Patients go home with ketamine lozenges or
nasal sprays to prolong the benefits. Some have gone six months or more without
needing a booster infusion, Watson said.
Family members often notice a dramatic turnaround in mood
after a patient's first 45-minute infusion, he said. Other patients only see
the benefit after several IV doses. Most find treatment peaceful and relaxing,
though it causes nausea in some, Watson said, and some dislike the feeling of
being disconnected from their body and the world.
But he said he's seen no issues with abuse at the low and
infrequent doses patients receive.
"There's still a lot we don't know, but even with what
we don't know, it's proved to be the most efficacious and rapid-acting drug
that we've ever seen for depression," Watson said. "It definitely
needs to be looked at."
Godfrey said ketamine has been nothing short of a miracle
for her. Before that, she had tried a series of antidepressants before finding
one that helped a bit, and everything from acupuncture to yoga and meditation.
But her gloom and pain never seemed to go away.
During her first ketamine infusion, however, Godfrey felt an
almost immediate sense of warmth and well-being, she said. Her second dose
brought "the presence of a being that said 'everything is going to be OK.'
"I didn't even realize how heavy the weight had gotten
until it was totally lifted," Godfrey said. "Immediately following
[an infusion], you have about 10 solid hours of no pain whatsoever, and it cut
down my actual pain by about 75 percent in a lasting way."
She continues to take the antidepressant Lexapro
(escitalopram) and sees a psychologist about once a month. When she needs it,
she puts a ketamine lozenge under her tongue at bedtime, and she drifts off to
sleep.
"I did not think that anything with this much relief
and promise would come along in my lifetime, let alone now," Godfrey said.
"It's a game-changer."
https://www.newsmax.com/health/health-news/controversial-depression-treatment/2018/12/19/id/895094/?ns_mail_uid=af2d6173-593a-4270-a0b8-d988f2ba9b95&ns_mail_job=DM10703_12202018&s=acs&dkt_nbr=01050232ndhz
No comments:
Post a Comment